Edition:
United States

PerkinElmer Inc (PKI)

PKI on New York Consolidated

72.31USD
17 Nov 2017
Change (% chg)

$0.01 (+0.01%)
Prev Close
$72.30
Open
$72.05
Day's High
$72.46
Day's Low
$71.68
Volume
614,116
Avg. Vol
620,454
52-wk High
$73.05
52-wk Low
$49.72

Chart for

About

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food,... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $7,969.62
Shares Outstanding(Mil.): 110.21
Dividend: 0.07
Yield (%): 0.39

Financials

  Industry Sector
P/E (TTM): -- 30.95 15.79
EPS (TTM): -- -- --
ROI: -- 10.03 12.01
ROE: -- 15.31 15.91

BRIEF-Perkinelmer Inc reports Q3 adjusted earnings per share $0.73

* Perkinelmer Inc announces financial results for the third quarter of 2017

Nov 02 2017

UPDATE 1-PerkinElmer third quarter profit edges past Street forecast

Nov 2 Laboratory equipment maker PerkinElmer Inc on Thursday reported slightly better-than-expected third-quarter profit and revenue and narrowed its full-year earnings forecast range while keeping the midpoint the same.

Nov 02 2017

PerkinElmer third quarter profit edges past Street forecast

Laboratory equipment maker PerkinElmer Inc on Thursday reported slightly better-than-expected third-quarter profit and revenue and narrowed its full-year earnings forecast range while keeping the midpoint the same.

Nov 02 2017

PerkinElmer third quarter profit edges past Street forecast

Nov 2 Laboratory equipment maker PerkinElmer Inc on Thursday reported slightly better-than-expected third-quarter profit and revenue and narrowed its full-year earnings forecast range while keeping the midpoint the same.

Nov 02 2017

PerkinElmer picks patent fight with Alere over blood testing kits

Scientific instrument maker PerkinElmer Inc on Monday filed a patent infringement lawsuit against diagnostic testing company Alere Inc, a subsidiary of health care giant Abbott Laboratories.

Oct 31 2017

LPC: Banks offer Excelitas bidders more than US$1bn in buyout debt

NEW YORK, Oct 6 Private equity firms preparing bids for US electronics and optical sensor component maker Excelitas Technologies Corp are being offered debt financing from banks between roughly US$1bn and US$1.1bn, two sources close to the matter said.

Oct 06 2017

BRIEF-PerkinElmer ‍announced upcoming retirement of Andy Wilson CFO

* PerkinElmer Inc - ‍Announced upcoming retirement of Andy Wilson, senior vice president and chief financial officer​

Sep 15 2017

BRIEF-PerkinElmer launches QSight210 MD system for clinical laboratories

* PerkinElmer Inc - launches QSight210 MD system for clinical laboratories Source text for Eikon: Further company coverage:

Sep 08 2017

BRIEF-PerkinElmer enters into 364-day unsecured term loan facility

* PerkinElmer Inc - ‍on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing​

Aug 15 2017

REFILE-BRIEF-PerkinElmer launches clinical whole genome sequencing services

* PerkinElmer launches clinical whole genome sequencing services

Aug 04 2017

Competitors

Earnings vs. Estimates